Revolutionizing Neck Rejuvenation: ABO Botulinum Toxin A Solution in Multipoint Technique and NASHA Gel Skinbooster

January 2024 | Volume 23 | Issue 1 | 1344 | Copyright © January 2024


Published online December 16, 2023

Ivano Iozzo MDa, Magda Belmontesi MDb, Carlo Di Gregorio MDc, Matteo Tretti Clementoni MDd, Valentina Angela Antonucci MDe

aCMIA Medical Center, Bologna, Italy
bStudio Medico Belmontesi, Vigevano, AGORA, Milan, Italy
cPlastic and Aesthetic Surgery, private practice, Palermo, Italy
dLaserplast SRL STP, Milan, Italy
eCMIA Medical Center, Bologna, Italy

Abstract
Background: Neck rejuvenation is an increasingly sought-after cosmetic procedure that offers a versatile solution to address various aging-related concerns in the neck area. Because it is non-surgical, it is an appealing choice for both patients and practitioners. This protocol introduces a highly effective approach utilizing ABO Botulinum Toxin A solution and NASHA gel 12 mg/mL for neck rejuvenation, targeting patients with muscle hypertonicity and skin degeneration. 
Materials and Methods: Patient selection is based on specific criteria. ABO Botulinum Toxin A solution is administered with tailored dosages and with a multipoint technique, followed by a structured NASHA gel skinbooster regimen. Precise injection techniques address muscle hypertonicity and improve skin quality. Follow-up appointments and personalized touch-up sessions maintain results.
Results: This is a minimally invasive, cost-effective approach with minimal downtime. ABO Botulinum Toxin A solution's precision and composition (efficacy) make it preferred. NASHA gel 12 mg/ml consistently enhances skin quality, providing tone, elasticity, hydration, and radiance. Gradual, long-lasting improvements boost patient satisfaction and confidence.
Conclusion: Physicians can expand their repertoire of treatment offerings with the combined use of ABO Botulinum Toxin A solution and NASHA gel 12 mg/ml for neck rejuvenation. This innovative approach aligns with ethical and environmental considerations, enhancing patient satisfaction and overall well-being. By learning and implementing this innovative protocol, aesthetic physicians can offer their patients a highly effective and sought-after (repetitioned) treatment option. 

J Drugs Dermatol. 2024;23(1):1344-1348.     doi:10.36849/JDD.8095

BACKGROUND

Neck rejuvenation has consistently ranked among the most sought-after cosmetic treatments. This area of the body presents a confluence of aging-related concerns, including skin deterioration, weakened ligaments, displacement of adipose tissue, increased platysma tension, and alterations in the jawline due to bone changes. In instances where a more extensive surgical intervention becomes necessary to restore tissue positioning and address excess skin and fat, surgical procedures are typically recommended for critical cases. However, for individuals who either don't meet the criteria for surgery or opt against it, alternative approaches involving injection techniques offer the opportunity to target and address the various facets of the aging process in the neck region.

INTRODUCTION

Our protocol investigates neck rejuvenation using injectable treatments, namely ABO Botulinum Toxin A solution (Alluzience, Ipsen Ltd, Slough, UK/Galderma SA, Lausanne, Switzerland) and NASHA (non-animal hyaluronic acid) gel 12 mg/ml as a skin booster. (Restylane Skinboosters, Vital Light lidocaine, QMED AB/Galderma, Uppsala, Sweden). Cases characterized by significant skin laxity or pronounced subcutaneous fat accumulation in the submental region are deemed ineligible for this specific treatment approach. 

This protocol is primarily intended for patients who exhibit concurrent skin degeneration and hypertonicity of the platysma and depressor muscles within the lower third of the face. Ideally, the most suitable candidates for this treatment are individuals for whom the predominant components of aging are muscle hypertonicity and skin degeneration. 

The utilization of Abobotulinum Toxin A solution has gained prominence as a noteworthy therapeutic approach for its ability to interrupt muscle hypertonicity and modulate muscle contraction, obtaining an aesthetic improvement resulting from muscle relaxation. Each vial of the solution contains 125
Close Menu